Filing Details
- Accession Number:
- 0001209191-23-042669
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-07-18 20:27:08
- Reporting Period:
- 2023-07-17
- Accepted Time:
- 2023-07-18 20:27:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1556263 | Syros Pharmaceuticals Inc. | SYRS | Pharmaceutical Preparations (2834) | 453772460 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1678149 | R Eric Olson | C/O Syros Pharmaceuticals, Inc. 35 Cambridgepark Drive Cambridge MA 02140 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-07-17 | 689 | $3.50 | 6,661 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported on this Form 4 was effected pursuant to a trading plan adopted on March 31, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Billionaire Hedge Funds
